Insider filing · BCYC
Baker Bros. Advisors (GP) LLC bought $21.1M of Bicycle Therapeutics (BCYC)
Executed Dec 13 2024, disclosed Dec 17 2024, 4 days later.
Value, as filed
$21.1M
1,477,015 sh across 8 lots
Executed
Dec 13 2024
the trade date, as filed
Disclosed
Dec 17 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
-11.1%
-15.8% from execution
Over the 21 trading sessions from the disclosed entry session (Dec 17 2024), the stock returned -11.1% (delay-adjusted); from the execution session (Dec 13 2024), -15.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
BL
Baker Bros. Advisors (GP) LLC
Director
profile →
Baker Bros. Advisors (GP) LLC (Director) filed 3 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 1 sale), most often in BCYC. Across 2 priced purchase filings, the average 21-session return was -9.0% from execution and -6.6% from disclosure (delay-adjusted; derived). The largest single filing was $190.5M of ONC (732,827 sh across 2 lots, as filed), executed Feb 28 2025.
The name
BCYC
BCYC
BCYC · 2 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→